Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)

NCT00627835 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Site decided not to open this study

Conditions

Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)

Interventions

DRUG: sorafenib
DRUG: sorafenib
DRUG: sorafenib and cisplatin
DRUG: sorafenib and cisplatin
DRUG: sorafenib and cisplatin

Sponsor

British Columbia Cancer Agency